FDA warns of scramble for workspaces and parking spots in Monday return to office
The U.S. Food and Drug Administration told staff this week it cannot guarantee workspaces or parking spots when they return ...
Trump admin live updates: Trump suggests Biden officials should be jailed
In a new Truth Social post Friday morning, President Donald Trump suggested that former President Joe Biden and other former ...
FDA warns of scramble for work and parking space in Monday return to office
The U.S. Food and Drug Administration told staff this week it cannot guarantee work space or parking spots among the hurdles ...
Healio8h
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Trump’s FDA and NIH picks clear committee, teeing up final Senate confirmation
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Dr. Marty Makary advances out of key committee in bid for FDA confirmation
President Donald Trump's nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote on Thursday morning.
Healio2d
How researchers were able to enroll adolescents in landmark HIV trial
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed ...
NJBIZ9d
FDA alerts NJ pharma over ‘misleading’ cancer drug claims at conference
According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.
STAT11d
FDA scolds drugmaker over promotion that touts ‘misleading’ comparison with generics
In a Feb. 3 letter posted on the FDA website this week ... a panel about its Hemady treatment for multiple myeloma in a conference exhibit booth. However, not only was there a lack of important ...
Monthly Prescribing Reference11d
FDA Approves Cortrophin Gel in Prefilled Syringe Presentation
The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. The new single-dose prefilled syringes ...
Monthly Prescribing Reference9d
FDA Approves Encelto for Macular Telangiectasia Type 2
References: Neurotech’s Encelto™ (revakinagene taroretcel-lwey) approved by the FDA for the treatment of macular telangiectasia type 2 (MacTel). News release Neurotech Pharmaceuticals.